North Bridge Venture Partners V-B LP's Form 4 filing
Lyra Therapeutics, Inc. (LYRA) · filed Apr 14, 2022
- Accession no.
- 0000899243-22-014796
- Filed
- Apr 14, 2022, 4:14 PM ET
- Trade date
- Apr 12, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $10.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| North Bridge Venture Partners V-B LPCIK 0001138399 | 10% Owner |
| North Bridge Venture Partners V A LPCIK 0001138402 | 10% Owner |
| Damore Richard ACIK 0001206641 | 10% Owner |
| North Bridge Venture Management V, L.P.CIK 0001297397 | 10% Owner |
| North Bridge Venture Partners VI L PCIK 0001327539 | 10% Owner |
| NBVM GP, LLCCIK 0001401650 | 10% Owner |
| North Bridge Venture Management VI, L.P.CIK 0001590898 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2022 | Common Stock | PPurchaseAcquired | +1,076,851 | $4.22 | +$4,544,311.22 | 1,855,443 | Indirect | Duplicate filing |
| Apr 12, 2022 | Common Stock | PPurchaseAcquired | +527,806 | $4.22 | +$2,227,341.32 | 909,424 | Indirect | Duplicate filing |
| Apr 12, 2022 | Common Stock | PPurchaseAcquired | +765,010 | $4.22 | +$3,228,342.2 | 1,318,133 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.